JP Patent

JP5222841B2 — リン酸オセルタミビル顆粒剤及びその調製方法

Assigned to インスティチュートオブファーマコロジーアンドトクシコロジーアカデミーオブミリタリーメディカルサイエンス、ピー．エル．エー．チャイナ · Expires 2013-06-26 · 13y expired

What this patent protects

Patent listed against lanthanum-carbonate.

Drugs covered by this patent

lanthanum-carbonate (LANTHANUM CARBONATE)

Patent Metadata

Patent number: JP5222841B2
Jurisdiction: JP
Classification: —
Expires: 2013-06-26
Drug substance claim: No
Drug product claim: No
Assignee: インスティチュートオブファーマコロジーアンドトクシコロジーアカデミーオブミリタリーメディカルサイエンス、ピー．エル．エー．チャイナ
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.